BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
Portfolio Pulse from Lisa Levin
Several stocks recorded losses in Thursday's trading session despite the overall market trading higher. BioXcel Therapeutics shares dropped 62.2% after releasing topline results from a Phase 3 trial. Liquidia Corporation fell 15% as it evaluates a patent claim from United Therapeutics. Other stocks that fell include Xiao-I Corporation, Disc Medicine Opco, Olema Pharmaceuticals, Minerva Neurosciences, Alvotech, Xeris Biopharma Holdings, Lilium N.V., Cricut, TuSimple Holdings, and Zura Bio Limited.
June 29, 2023 | 3:23 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BioXcel Therapeutics shares dropped 62.2% after releasing topline results from a Phase 3 trial.
The significant drop in BioXcel Therapeutics' share price is directly related to the release of its Phase 3 trial results. This negative news is likely to continue impacting the stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Liquidia Corporation fell 15% as it evaluates a patent claim from United Therapeutics.
Liquidia Corporation's share price fell as the company evaluates a patent claim from United Therapeutics. This uncertainty could continue to negatively impact the stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100